Lipowska Anna M, Kavitt Robert T
Dr Lipowska is a gastroenterology fellow and Dr Kavitt is an assistant professor of medicine and director of the Center for Esophageal Diseases in the Section of Gastroenterology, Hepatology, and Nutrition at The University of Chicago Medicine in Chicago, Illinois.
Gastroenterol Hepatol (N Y). 2017 Sep;13(9):527-535.
Eosinophilic esophagitis (EoE) is a chronic inflammatory disorder of the esophagus diagnosed by the presence of esophageal symptoms accompanied by an esophageal eosinophilic infiltrate. EoE has an increasing worldwide prevalence and can be a cause of dysphagia and food impactions. There is an important role for the use of proton pump inhibitors in the diagnostic pathway of EoE. Treatment paradigms for EoE aim to minimize esophageal inflammation and improve symptom control. Dietary therapy targets dietary allergens and encompasses the elemental diet, the allergy testing-directed elimination diet, and the empiric elimination diet. Pharmacologic options include topical corticosteroids as the standard first-line treatment. Multiple other pharmacologic interventions are currently under investigation and are not recommended in the most recent guidelines. Endoscopic dilation is usually reserved for patients who relapse on pharmacologic or dietary regimens or who have symptomatic stricturing disease. This article provides a comprehensive discussion of existing diagnostic and management strategies for EoE.
嗜酸性食管炎(EoE)是一种食管慢性炎症性疾病,通过食管症状伴食管嗜酸性粒细胞浸润来诊断。EoE在全球的患病率不断上升,可导致吞咽困难和食物嵌塞。质子泵抑制剂在EoE的诊断途径中具有重要作用。EoE的治疗模式旨在尽量减少食管炎症并改善症状控制。饮食疗法针对饮食过敏原,包括要素饮食、过敏测试导向的排除饮食和经验性排除饮食。药物选择包括局部使用皮质类固醇作为标准的一线治疗。目前正在研究多种其他药物干预措施,最新指南不推荐使用。内镜扩张通常适用于药物或饮食方案治疗后复发或有症状性狭窄疾病的患者。本文全面讨论了EoE现有的诊断和管理策略。